title: Pharmaceuticals. Plunder and pillage.
abstract: The government has proposed a statutory scheme to regulate prices and profits on the sale of drugs to the NHS. Drug companies which don't cooperate could be liable to heavy fines, but the government has failed to spell out the precise conditions under which such penalties would apply. Defining what comprises excessive prices or profits is likely to present a number of empirical problems. Experience overseas suggests that the scheme will fail to halt the inexorable rise in the NHS drugs bill.
authors.affiliation: Department of Medicines Management, Keele University.
authors.forename: A
authors.initials: A
authors.lastname: Earl-Slater
mesh_terms: D003132:Commerce / Q000191:economics / Q000331:legislation & jurisprudence; D003363:Cost Control / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence* / Q000639:trends; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D007250:Inflation, Economic; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom